Access to skin care and beauty products for cancer patients
Official title: Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
Run by Institut de cancérologie Strasbourg Europe · NCT05907551 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at how well cancer patients with solid tumors can access skin care and beauty products to help with side effects from their treatments and whether they can afford them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 210 (estimated) |
| Sponsor | Institut de cancérologie Strasbourg Europe Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT05907551 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old who have been diagnosed with solid tumors and can read and understand French.
✕Probably not a fit
Patients who are minors, unable to read French, or under judicial protection will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients with solid tumors to assess their knowledge, access, and financial capacity regarding dermo-cosmetics and aesthetic solutions that can help alleviate the side effects of cancer treatments. By utilizing questionnaires, the study aims to gather data on how these products can improve the quality of life for patients experiencing cutaneous, nail, and hair toxicities due to their treatments. The findings may highlight disparities in access to supportive care that is often not covered by health insurance.
Why it matters
Potential benefit: If successful, this study could improve access to essential skin care and beauty products for cancer patients, enhancing their quality of life during treatment.
How similar studies have gone: While there may be limited studies specifically addressing access to dermo-cosmetics for cancer patients, the approach of assessing patient knowledge and access to supportive care is increasingly recognized as important in oncology.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * Patients with solid tumors (eligible localization include: digestive system, Head and Neck, Breast, Brain, Lung Tumors, Urological and Gynecologic cancers) * Patients able to read and understand French * Patients that has expressed their consent and with signed consent form Exclusion Criteria: * Minor or patients placed under guardianship or supervision * Patients unable to read French * Patients placed under judicial protection
Where it's running
-
Institut de cancérologie Strasbourg Europe
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Manon VOEGELIN
- Email: promotion-rc@icans.eu
- Phone: (0)3 68 33 95 23
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
HR20013 for preventing nausea and vomiting in cancer patients receiving chemotherapy
This real-world study tests whether HR20013 helps prevent nausea and vomiting in adults with cancer who are getting chemotherapy.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Ready for Safe Cancer Treatment (RESET): A comprehensive perioperative program for surgical patients
The RESET program tests a structured, multidisciplinary perioperative plan to improve safety and recovery for adults having planned cancer surgery and older adults having planned non cancer-related surgery.
-
How environment and biology together predict health, aging, and death
Researchers are following adults to see how living conditions and biology together relate to aging and life expectancy, by linking personal health data with environmental and social information over time.
-
Metastatic liver cancer patient registry from multiple Chinese centers
This is a registry that collects real-world data on adults with liver metastases to understand patterns and prognosis and to support future research.
-
TriAdeno and N-803 vaccine in early prostate cancer on active surveillance
A vaccine combo called TriAdeno plus the N-803 drug is being tested to see if it can help slow or stop growth in men with early-stage, low- to intermediate-risk prostate cancer who are being watched rather than treated right away.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.